Borg JP - Search Results

1

Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively.

Mattei MG, Borg JP, Rosnet O, Marmé D, Birnbaum D. Mattei MG, et al. Among authors: borg jp. Genomics. 1996 Feb 15;32(1):168-9. doi: 10.1006/geno.1996.0098. Genomics. 1996. PMID: 8786112 No abstract available.

2

Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor.

Fournier E, Dubreuil P, Birnbaum D, Borg JP. Fournier E, et al. Among authors: borg jp. Oncogene. 1995 Sep 7;11(5):921-31. Oncogene. 1995. PMID: 7675451

3

Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase.

Borg JP, deLapeyrière O, Noguchi T, Rottapel R, Dubreuil P, Birnbaum D. Borg JP, et al. Oncogene. 1995 Mar 2;10(5):973-84. Oncogene. 1995. PMID: 7898938

4

The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor.

Galland F, Karamysheva A, Pebusque MJ, Borg JP, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D. Galland F, et al. Among authors: borg jp. Oncogene. 1993 May;8(5):1233-40. Oncogene. 1993. PMID: 8386825

5

Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase.

Fournier E, Rosnet O, Marchetto S, Turck CW, Rottapel R, Pelicci PG, Birnbaum D, Borg JP. Fournier E, et al. Among authors: borg jp. J Biol Chem. 1996 May 31;271(22):12956-63. doi: 10.1074/jbc.271.22.12956. J Biol Chem. 1996. PMID: 8662748 Free article.

6

[Receptors for factors of the VEGF (Vascular Endothelial Growth Family)].

Fournier E, Birnbaum D, Borg JP. Fournier E, et al. Among authors: borg jp. Bull Cancer. 1997 Apr;84(4):397-405. Bull Cancer. 1997. PMID: 9238164 Review. French.

7

Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF receptor 3 signaling.

Fournier E, Blaikie P, Rosnet O, Margolis B, Birnbaum D, Borg JP. Fournier E, et al. Among authors: borg jp. Oncogene. 1999 Jan 14;18(2):507-14. doi: 10.1038/sj.onc.1202315. Oncogene. 1999. PMID: 9927207

8

SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor.

Marchetto S, Fournier E, Beslu N, Aurran-Schleinitz T, Dubreuil P, Borg JP, Birnbaum D, Rosnet O. Marchetto S, et al. Among authors: borg jp. Leukemia. 1999 Sep;13(9):1374-82. doi: 10.1038/sj.leu.2401527. Leukemia. 1999. PMID: 10482988

9

ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor.

Borg JP, Marchetto S, Le Bivic A, Ollendorff V, Jaulin-Bastard F, Saito H, Fournier E, Adélaïde J, Margolis B, Birnbaum D. Borg JP, et al. Nat Cell Biol. 2000 Jul;2(7):407-14. doi: 10.1038/35017038. Nat Cell Biol. 2000. PMID: 10878805

10

The ERBB2/HER2 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins.

Jaulin-Bastard F, Saito H, Le Bivic A, Ollendorff V, Marchetto S, Birnbaum D, Borg JP. Jaulin-Bastard F, et al. Among authors: borg jp. J Biol Chem. 2001 May 4;276(18):15256-63. doi: 10.1074/jbc.M010032200. Epub 2001 Feb 5. J Biol Chem. 2001. PMID: 11278603 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters